Skip to content

Accelerated Flap Coverage Versus Standard Timing in the Treatment of Severe Lower Extremity Musculoskeletal Injuries (*FLAP ATTACK*). Pilot trial.

Accelerated Flap Coverage Versus Standard Timing in the Treatment of Severe Lower Extremity Musculoskeletal Injuries (*FLAP ATTACK*). Pilot trial. - FLAP ATTACK Pilot trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57462
Enrollment
9
Registered
2025-05-08
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open fracture Severe Lower Extremity Musculoskeletal Injuries

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Patients 16 years of age or older. 2) Severe lower extremity open fracture and/or dislocation below the knee requiring an acute flap for management of the musculoskeletal injury. 3) Will have all planned flap surgeries performed by a participating surgeon or delegate. 4) Able to be randomized within 48 hours of injury.

Exclusion criteria

Exclusion criteria: 1) Site is unable to implement the accelerated flap protocol due to local logistics. 2) Primary amputation anticipated prior to attempted flap for management of the injury. 3) Critical limb ischemia that requires re-vascularization for limb perfusion. 4) Chronic or acute infection at or near the musculoskeletal injury site at the time of initial injury surgery. 5) Burns at the musculoskeletal injury site. 6) Incarceration. 7) Currently enrolled in a trial that does not permit co-enrollment. 8) Declined to provide informed consent. 9) Unable to obtain informed consent due to language barriers. 10) Unable to obtain informed consent because a legally authorized representative was unavailable. 11) Anticipated problems, in the judgment of research personnel, with maintaining follow-up with the patient. 12) Prior enrollment in the trial.

Design outcomes

Primary

MeasureTime frame
Pilot study primary outcome: Number of patients that we can recruit within a one-year timeframe.

Secondary

MeasureTime frame
Pilot study secondary outcomes: 1) Patient reported function, satisfaction and quality of life 2) Medical costs and productivity loss. 3) Injury-related amputation of the lower extremity; 4) Unplanned reoperations to manage infection, flap compromise, or flap loss; 5) Days in the hospital; 6) Mortality; 7) loss to follow-up

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)